Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$14.15 - $19.5 $591,554 - $815,217
41,806 Added 28.36%
189,193 $2.85 Million
Q2 2022

Aug 12, 2022

BUY
$11.81 - $20.92 $90,181 - $159,745
7,636 Added 5.46%
147,387 $1.97 Million
Q1 2022

May 13, 2022

BUY
$16.97 - $25.0 $504,874 - $743,775
29,751 Added 27.05%
139,751 $2.69 Million
Q4 2021

Feb 11, 2022

BUY
$16.22 - $29.69 $1.78 Million - $3.27 Million
110,000 New
110,000 $2.61 Million

Others Institutions Holding IMGO

About Imago BioSciences, Inc.


  • Ticker IMGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,741,600
  • Description
  • Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...
More about IMGO
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.